These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 3119787

  • 1. Antineoplastic effects of tumor necrosis factor alone and in combination with gamma-interferon on tumor biopsies in clonogenic assay.
    Salmon SE, Young L, Scuderi P, Clark B.
    J Clin Oncol; 1987 Nov; 5(11):1816-21. PubMed ID: 3119787
    [Abstract] [Full Text] [Related]

  • 2. Synergistic enhancement of class I major histocompatibility complex antigen expression in K562 cells induced by recombinant human interferon-gamma and tumor necrosis factor in combination.
    Takemura Y, Koide Y, Kawabata M, Kitajima S, Ohba C, Suzuki H, Sekiguchi S.
    Exp Hematol; 1989 Aug; 17(7):795-9. PubMed ID: 2502422
    [Abstract] [Full Text] [Related]

  • 3. Antileukemic effect of recombinant tumor necrosis factor alpha in vitro and its modulation by alpha and gamma interferons.
    Beran M, McCredie KB, Keating MJ, Gutterman JU.
    Blood; 1988 Aug; 72(2):728-38. PubMed ID: 3135864
    [Abstract] [Full Text] [Related]

  • 4. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.
    Lienard D, Ewalenko P, Delmotte JJ, Renard N, Lejeune FJ.
    J Clin Oncol; 1992 Jan; 10(1):52-60. PubMed ID: 1727926
    [Abstract] [Full Text] [Related]

  • 5. Influence of tumor necrosis factor-alpha on the modulation by interferon-gamma of HLA class II molecules in human thyroid cells and its effect on interferon-gamma binding.
    Buscema M, Todd I, Deuss U, Hammond L, Mirakian R, Pujol-Borrell R, Bottazzo GF.
    J Clin Endocrinol Metab; 1989 Aug; 69(2):433-9. PubMed ID: 2502555
    [Abstract] [Full Text] [Related]

  • 6. Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma.
    Ruggiero V, Tavernier J, Fiers W, Baglioni C.
    J Immunol; 1986 Apr 01; 136(7):2445-50. PubMed ID: 3005411
    [Abstract] [Full Text] [Related]

  • 7. Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells.
    Murphy M, Perussia B, Trinchieri G.
    Exp Hematol; 1988 Feb 01; 16(2):131-8. PubMed ID: 3123270
    [Abstract] [Full Text] [Related]

  • 8. Phase I study of a combination of recombinant tumor necrosis factor-alpha and recombinant interferon-gamma in cancer patients.
    Kurzrock R, Feinberg B, Talpaz M, Saks S, Gutterman JU.
    J Interferon Res; 1989 Aug 01; 9(4):435-44. PubMed ID: 2502584
    [Abstract] [Full Text] [Related]

  • 9. Diversity of the effect of recombinant tumor necrosis factors alpha and beta on human myelogenous leukemia cell lines.
    Beran M, Andersson BS, Kelleher P, Whalen K, McCredie K, Gutterman J.
    Blood; 1987 Mar 01; 69(3):721-6. PubMed ID: 3028534
    [Abstract] [Full Text] [Related]

  • 10. Cytokine-mediated modulation of HLA-class II, ICAM-1, LFA-3 and tumor-associated antigen profile of melanoma cells. Comparison with anti-proliferative activity by rIL1-beta, rTNF-alpha, rIFN-gamma, rIL4 and their combinations.
    Mortarini R, Belli F, Parmiani G, Anichini A.
    Int J Cancer; 1990 Feb 15; 45(2):334-41. PubMed ID: 1689276
    [Abstract] [Full Text] [Related]

  • 11. Cytokines and pancreatic cancer. The effect of rIFN-gamma, HuLeIFN, rTNF-alpha, and LAK-cells on pancreatic and other gastrointestinal tumors in vitro.
    Kühl JS, Klapdor R, Mohr H, Arps H, Dietel M.
    Int J Pancreatol; 1989 Mar 15; 4(2):207-19. PubMed ID: 2498436
    [Abstract] [Full Text] [Related]

  • 12. Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor.
    Gajewski TF, Goldwasser E, Fitch FW.
    J Immunol; 1988 Oct 15; 141(8):2635-42. PubMed ID: 2971726
    [Abstract] [Full Text] [Related]

  • 13. In vivo effects of human recombinant tumor necrosis factor alone and in combination with other biological response modifiers on human digestive organ cancer xenografts transplanted in nude mice.
    Nio Y, Shiraishi T, Tsubono M, Morimoto H, Tseng CC, Kawabata K, Masai Y, Tun T, Fukumoto M, Tobe T.
    Biotherapy; 1991 Oct 15; 3(4):337-44. PubMed ID: 1786197
    [Abstract] [Full Text] [Related]

  • 14. Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages.
    Drapier JC, Wietzerbin J, Hibbs JB.
    Eur J Immunol; 1988 Oct 15; 18(10):1587-92. PubMed ID: 3142779
    [Abstract] [Full Text] [Related]

  • 15. Effect of prolactin, rIFN-gamma or rTNF-alpha in murine toxoplasmosis.
    Benedetto N, Folgore A, Galdiero M, Meli R, Di Carlo R.
    Pathol Biol (Paris); 1995 May 15; 43(5):395-400. PubMed ID: 8532376
    [Abstract] [Full Text] [Related]

  • 16. Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production. Evidence for cytokine-regulated hyaluronan (hyaluronic acid) degradation and human lung fibroblast-derived hyaluronidase.
    Sampson PM, Rochester CL, Freundlich B, Elias JA.
    J Clin Invest; 1992 Oct 15; 90(4):1492-503. PubMed ID: 1401082
    [Abstract] [Full Text] [Related]

  • 17. Tumor necrosis factor and immune interferon synergistically induce cytochrome b-245 heavy-chain gene expression and nicotinamide-adenine dinucleotide phosphate hydrogenase oxidase in human leukemic myeloid cells.
    Cassatella MA, Hartman L, Perussia B, Trinchieri G.
    J Clin Invest; 1989 May 15; 83(5):1570-9. PubMed ID: 2496143
    [Abstract] [Full Text] [Related]

  • 18. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson SL, Beyer GS, Hoffman R, Rubin BY.
    J Immunol; 1986 Jun 15; 136(12):4487-95. PubMed ID: 3086433
    [Abstract] [Full Text] [Related]

  • 19. Synergy is documented in vitro with low-dose recombinant tumor necrosis factor, cisplatin, and doxorubicin in ovarian cancer cells.
    Bonavida B, Tsuchitani T, Zighelboim J, Berek JS.
    Gynecol Oncol; 1990 Sep 15; 38(3):333-9. PubMed ID: 2227544
    [Abstract] [Full Text] [Related]

  • 20. Effects of scheduling and ascites-associated macrophages on combined antiproliferative activity of alpha-2b interferon and gamma-interferon in a clonogenic assay.
    Higashihara J, Saito T, Berens ME, Welander CE.
    Cancer Chemother Pharmacol; 1988 Sep 15; 22(3):215-22. PubMed ID: 3136942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.